Interstitial lung disease (ILD) comprises a heterogenous group of diffuse lung disorders that
commonly result in irreversible pulmonary fibrosis. While idiopathic pulmonary fibrosis (IPF) …

Interstitial lung diseases (ILDs) are a large group of pulmonary disorders characterized
histologically by the cardinal involvement of the pulmonary interstitium. The prototype of …

Idiopathic pulmonary fibrosis is a chronic, fibrosing interstitial pneumonia that presents with
various clinical courses and progression ranging from rapid to slow. To identify novel …

Interstitial lung diseases comprise a heterogenous range of diffuse lung disorders,
potentially resulting in pulmonary fibrosis. While idiopathic pulmonary fibrosis has been …

Considering recently published two guidelines for the diagnosis of hypersensitivity
pneumonitis (HP), the Japanese Respiratory Society (JRS) has now published its own …

Asthma is a heterogeneous pulmonary disorder, the progression and chronization of which
leads to airway remodeling and fibrogenesis. To understand the molecular mechanisms of …

Background The endogenous secretory receptor for advanced glycation end products
(esRAGE) is a soluble isoform produced by alternative splicing of the RAGE gene. The …

Hypersensitivity pneumonitis is a complex interstitial lung syndrome and is associated with
significant morbimortality, particularly for fibrotic disease. This condition is characterized by …

Although radiotherapy is a common form of treatment for head and neck cancer, it may lead
to tissue damage in the salivary and lacrimal glands, possibly affecting cytokine expression …

Background Checkpoint inhibitor pneumonitis (CIP) is a potentially fatal adverse event
resulting from immunotherapy in patients with malignant tumors. However, the pathogenesis …